Search Results - "De Kort, Sandra W. K."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Preterm birth does not affect bone mineral density in young adults by Breukhoven, Petra E, Leunissen, Ralph W J, de Kort, Sandra W K, Willemsen, Ruben H, Hokken-Koelega, Anita C S

    Published in European journal of endocrinology (01-01-2011)
    “…ObjectivePrevious studies showed conflicting data on the effect of prematurity on bone mineral density (BMD) in infants and children. Only a few studies…”
    Get full text
    Journal Article
  2. 2

    The PPAR-γ Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age by de Kort, Sandra W K, Hokken-Koelega, Anita C S

    Published in European journal of endocrinology (01-01-2010)
    “…ContextShort children born small for gestational age (SGA) have a lean phenotype with lower insulin sensitivity and higher blood pressure. GH treatment results…”
    Get full text
    Journal Article
  3. 3

    Independent Effects of Prematurity on Metabolic and Cardiovascular Risk Factors in Short Small-for-Gestational-Age Children by Willemsen, Ruben H., de Kort, Sandra W. K., van der Kaay, Danielle C. M., Hokken-Koelega, Anita C. S.

    “…Context: Both small-for-gestational-age (SGA) and preterm birth have been associated with an increased incidence of adult cardiovascular disease and diabetes…”
    Get full text
    Journal Article
  4. 4

    Serum Insulin-Like Growth Factor-Binding Protein-2 Levels and Metabolic and Cardiovascular Risk Factors in Young Adults and Children Born Small for Gestational Age by de Kort, Sandra W. K, van Doorn, Jaap, van de Sande, Ad G. M, Leunissen, Ralph W. J, Hokken-Koelega, Anita C. S

    “…Background: IGF binding protein (IGFBP)-2 might protect against cardiovascular disease. Small for gestational age (SGA) birth could be associated with a higher…”
    Get full text
    Journal Article
  5. 5

    Type 2 diabetes gene TCF7L2 polymorphism is not associated with fetal and postnatal growth in two birth cohort studies by Mook-Kanamori, Dennis O, de Kort, Sandra W K, van Duijn, Cornelia M, Uitterlinden, Andre G, Hofman, Albert, Moll, Henriëtte A, Steegers, Eric A P, Hokken-Koelega, Anita C S, Jaddoe, Vincent W V

    Published in BMC medical genetics (17-07-2009)
    “…An inverse association between birth weight and the risk of developing type 2 diabetes (T2D) in adulthood has been reported. This association may be explained…”
    Get full text
    Journal Article
  6. 6

    The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children by De Kort, Sandra W. K., Willemsen, Ruben H., Van Der Kaay, Danielle C. M., Hokken-Koelega, Anita C. S.

    Published in Clinical endocrinology (Oxford) (01-07-2009)
    “…Summary Context  We previously reported that short, small for gestational age (SGA) children who were born preterm have a lower body fat percentage and a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children? by De Kort, Sandra W. K., Willemsen, Ruben H., Van Der Kaay, Danielle C. M., Duivenvoorden, Hugo J., Hokken-Koelega, Anita C. S.

    Published in Clinical endocrinology (Oxford) (01-04-2009)
    “…Summary Objective  To investigate whether prematurity has an independent influence on the response to GH treatment in short, small for gestational age (SGA)…”
    Get full text
    Journal Article
  9. 9

    Infliximab in a child with therapy-resistant systemic vasculitis by de Kort, Sandra W K, van Rossum, Marion A J, ten Cate, Rebecca

    Published in Clinical rheumatology (01-09-2006)
    “…Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with…”
    Get full text
    Journal Article
  10. 10

    Should short children born small for gestational age with a distance to target height <1 standard deviation score be excluded from growth hormone treatment? by LEM, Annemieke J, DE KORT, Sandra W. K, DE RIDDER, Maria A. J, HOKKEN-KOELEGA, Anita C. S

    Published in Clinical endocrinology (Oxford) (01-09-2010)
    “…The criteria for starting growth hormone (GH), an approved treatment for short children born small for gestational age (SGA), differ between Europe and the…”
    Get full text
    Journal Article
  11. 11

    Interactions between TCF7L2 genotype and growth hormone-induced changes in glucose homeostasis in small for gestational age children by De Kort, Sandra W. K., Mook-Kanamori, Dennis O., Jaddoe, Vincent W. V., Hokken-Koelega, Anita C. S.

    Published in Clinical endocrinology (Oxford) (01-01-2010)
    “…Summary Context  The Transcription factor 7‐like 2 (TCF7L2) rs7903146 gene polymorphism has been associated with risk of developing type 2 diabetes mellitus…”
    Get full text
    Journal Article
  12. 12

    Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment by Willemsen, Ruben H., Van Dijk, Marije, De Kort, Sandra W. K., Van Toorenenbergen, Albert W., Hokken-Koelega, Anita C. S.

    Published in Clinical endocrinology (Oxford) (01-08-2008)
    “…Summary Context  Short small‐for‐gestational‐age (SGA) children have an increased systolic blood pressure (BP) that decreases during long‐term GH treatment…”
    Get full text
    Journal Article
  13. 13

    Cardiovascular Risk Factors in Parents of Short Children Born Small for Gestational Age by de Kort, Sandra W K, van Dijk, Marije, Willemsen, Ruben H, Ester, Wietske A, Viet, Lucie, de Rijke, Yolanda B, Hokken-Koelega, Anita C S

    Published in Pediatric research (01-07-2008)
    “…Small for gestational age (SGA) children have a higher prevalence of cardiovascular risk factors at a young age. It is not known whether this increased risk is…”
    Get full text
    Journal Article
  14. 14

    ORIGINAL ARTICLE: Should short children born small for gestational age with a distance to target height <1 standard deviation score be excluded from growth hormone treatment? by Lem, Annemieke J., De Kort, Sandra W. K., De Ridder, Maria A. J., Hokken-Koelega, Anita C. S.

    Published in Clinical endocrinology (Oxford) (01-09-2010)
    “…Summary Context  The criteria for starting growth hormone (GH), an approved treatment for short children born small for gestational age (SGA), differ between…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Myocardial infarction in a 16-year old following inhalation of butane gas by De Naeyer, Ann H R R, de Kort, Sandra W K, Portegies, Mireille C M, Deraedt, Dirk J D L, Buysse, Corinne M P

    “…Butane gas is inhaled by young people with the aim of getting 'high'. This can cause coronary spasm with myocardial infarction and ventricular fibrillation as…”
    Get more information
    Journal Article